Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Decheng Meng

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Journal of Cardiovascular Pharmacology and Therapeutics|April 24, 2024
The Role of JAK/STAT Signaling Pathway and Its Downstream Influencing Factors in the Treatment of AtherosclerosisXin Zhang, Suwen Chen, Guoliang Yin, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|October 25, 2024
Hesperitin prevents non-alcoholic steatohepatitis by modulating mitochondrial dynamics and mitophagy via the AMPKα-Drp1/PINK1-Parkin signaling pathwaySuwen Chen, Haifei Lu, Guoliang Yin, et al.
ACS Applied Materials & Interfaces|October 25, 2023
Transparent, Mechanically Robust, Adhesive, Temperature-Tolerant, and 3D Printable Nanocomposite Ionogels for Flexible SensorsZilian Yu, Nanbin Bao, Huan Liu, et al.
International Immunopharmacology|June 30, 2024
Diosgenin attenuates metabolic-associated fatty liver disease through the hepatic NLRP3 inflammasome-dependent signaling pathwayWenfei Yu, Guoliang Yin, Suwen Chen, et al.
European Journal of Pharmacology|June 12, 2024
Diosgenin attenuates nonalcoholic hepatic steatosis through the hepatic SIRT1/PGC-1α pathwayDecheng Meng, Guoliang Yin, Suwen Chen, et al.
Chemico-Biological Interactions|November 13, 2024
Diosgenin attenuates nonalcoholic fatty liver disease through mTOR-mediated inhibition of lipid accumulation and inflammationGuoliang Yin, Hongyi Liang, Yiran Cheng, et al.
The Journal of Nutritional Biochemistry|March 1, 2025
Diosgenin alleviates lipid accumulation in NAFLD through the pathways of ferroptosis defensive and executive systemLinya Wang, Hongzhuan Yu, Dongxian Wang, et al.
European Journal of Pharmacology|June 1, 2023
Diosgenin attenuates nonalcoholic hepatic steatosis through the hepatic FXR-SHP-SREBP1C/PPARα/CD36 pathwaySuwen Chen, Shangwen Sun, Yanan Feng, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 17, 2024
Multi-material 3D printed eutectogel microneedle patches integrated with fast customization and tunable drug deliveryHuan Liu, Xinmeng Zhou, Aminov Nail, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 5, 2025
Association Between the Amount of Carotid Perivascular Adipose Tissue and Prior Ischemic Stroke: An MR Imaging StudyShuwan Yu, Ran Huo, Xueyi Chen, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal of Cardiovascular Pharmacology and Therapeutics|April 24, 2024
The Role of JAK/STAT Signaling Pathway and Its Downstream Influencing Factors in the Treatment of AtherosclerosisXin Zhang, Suwen Chen, Guoliang Yin, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|October 25, 2024
Hesperitin prevents non-alcoholic steatohepatitis by modulating mitochondrial dynamics and mitophagy via the AMPKα-Drp1/PINK1-Parkin signaling pathwaySuwen Chen, Haifei Lu, Guoliang Yin, et al.
ACS Applied Materials & Interfaces|October 25, 2023
Transparent, Mechanically Robust, Adhesive, Temperature-Tolerant, and 3D Printable Nanocomposite Ionogels for Flexible SensorsZilian Yu, Nanbin Bao, Huan Liu, et al.
International Immunopharmacology|June 30, 2024
Diosgenin attenuates metabolic-associated fatty liver disease through the hepatic NLRP3 inflammasome-dependent signaling pathwayWenfei Yu, Guoliang Yin, Suwen Chen, et al.
European Journal of Pharmacology|June 12, 2024
Diosgenin attenuates nonalcoholic hepatic steatosis through the hepatic SIRT1/PGC-1α pathwayDecheng Meng, Guoliang Yin, Suwen Chen, et al.
Chemico-Biological Interactions|November 13, 2024
Diosgenin attenuates nonalcoholic fatty liver disease through mTOR-mediated inhibition of lipid accumulation and inflammationGuoliang Yin, Hongyi Liang, Yiran Cheng, et al.
The Journal of Nutritional Biochemistry|March 1, 2025
Diosgenin alleviates lipid accumulation in NAFLD through the pathways of ferroptosis defensive and executive systemLinya Wang, Hongzhuan Yu, Dongxian Wang, et al.
European Journal of Pharmacology|June 1, 2023
Diosgenin attenuates nonalcoholic hepatic steatosis through the hepatic FXR-SHP-SREBP1C/PPARα/CD36 pathwaySuwen Chen, Shangwen Sun, Yanan Feng, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 17, 2024
Multi-material 3D printed eutectogel microneedle patches integrated with fast customization and tunable drug deliveryHuan Liu, Xinmeng Zhou, Aminov Nail, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 5, 2025
Association Between the Amount of Carotid Perivascular Adipose Tissue and Prior Ischemic Stroke: An MR Imaging StudyShuwan Yu, Ran Huo, Xueyi Chen, et al.
Pageof 4